Quinn Opportunity Partners’s Acceleron Pharma XLRN Stock Holding History

Quinn Opportunity Partners’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,208	Closed	-$7.09M	–	290
2021 Q3	$7.09M	Buy	+41,208	New	+$5.39M	0.45%	47

Quinn Opportunity Partners's XLRN Position: Q4 2021 in Review

Quinn Opportunity Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 41,208 shares — an estimated $7.09M sold.

Quinn Opportunity Partners first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $7.09M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Quinn Opportunity Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Quinn Opportunity Partners sold 41,208 Acceleron Pharma shares in Q4 2021, an estimated $7.09M.
Quinn Opportunity Partners first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Quinn Opportunity Partners's Acceleron Pharma position peaked at $7.09M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Quinn Opportunity Partners's 13F filing for Q4 2021, filed 14 Feb 2022.